MENU
+Compare
KMDA
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$6.62
Change
+$0.04 (+0.61%)
Capitalization
306.49M

KMDA Kamada Ltd Forecast, Technical & Fundamental Analysis

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company... Show more

Industry: #Biotechnology
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KMDA with price predictions
Apr 24, 2025

Momentum Indicator for KMDA turns positive, indicating new upward trend

KMDA saw its Momentum Indicator move above the 0 level on April 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KMDA's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KMDA just turned positive on April 16, 2025. Looking at past instances where KMDA's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KMDA advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

KMDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

KMDA moved below its 50-day moving average on March 26, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KMDA entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.323) is normal, around the industry mean (61.504). P/E Ratio (37.433) is within average values for comparable stocks, (90.857). KMDA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.115) is also within normal values, averaging (19.413).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

View a ticker or compare two or three
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KMDA is expected to report earnings to fall 4.71% to 6 cents per share on May 27

Kamada Ltd KMDA Stock Earnings Reports
Q1'25
Est.
$0.07
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.11
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.03
The last earnings report on March 05 showed earnings per share of 7 cents, beating the estimate of 5 cents. With 41.67K shares outstanding, the current market capitalization sits at 306.49M.
A.I. Advisor
published General Information

General Information

a company, which engages in pharmaceutical business

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFSX7.17N/A
N/A
Manning & Napier Disciplined Value S
GCVRX21.74N/A
N/A
Goldman Sachs Large Cp Val Insghts R
SAMVX10.61N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
LGLAX40.41N/A
N/A
Lord Abbett Growth Leaders A
GAMNX9.95N/A
N/A
Gabelli Global Mini Mites AAA

KMDA and Stocks

Correlation & Price change

A.I.dvisor tells us that KMDA and RDY have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and RDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+0.61%
RDY - KMDA
33%
Poorly correlated
+2.34%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
-0.48%
INCR - KMDA
26%
Poorly correlated
-6.01%
ASRT - KMDA
25%
Poorly correlated
+4.20%
More